Role of Rab GTPases in Hepatocellular Carcinoma
Chun-Cheng Yang,1,* Guang-Xiao Meng,1,* Zhao-Ru Dong,1,* Tao Li1,2 1Department of General Surgery, Qilu Hospital, Shandong University, Jinan, People’s Republic of China; 2Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, People’s Republic...
Saved in:
Main Authors: | Yang CC, Meng GX, Dong ZR, Li T |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/8934e8c52eb3484a95d672ce9a3b388b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
by: L. V. Bolotina
Published: (2020) -
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Pomej K, et al.
Published: (2021) -
Nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis
by: Pasquale Cervero, et al.
Published: (2021) -
Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson’s Disease
by: José Ángel Martínez-Menárguez, et al.
Published: (2021) -
Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol
by: Jiang Bo, et al.
Published: (2021)